Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 42
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients’ selection 2018 Menis, JessicaRUSSO, ANTONIO + CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - -
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines? 2018 MENIS, JESSICA + BRITISH JOURNAL OF CANCER - -
Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score) 2017 Menis, Jessica + EUROPEAN JOURNAL OF CANCER - -
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: A subset analysis of EORTC 24971 study 2017 Menis, J. + ANNALS OF ONCOLOGY - -
TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: A randomized phase II EORTC trial 2017 MENIS, JESSICA + ANNALS OF ONCOLOGY - -
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613 2017 Menis J. + CLINICAL LUNG CANCER - -
Long-term update of the 24954 EORTC phase III trial on larynx preservation 2016 Menis J. + EUROPEAN JOURNAL OF CANCER - -
The European Organization for Research and Treatment of Cancer perspective on designing clinical trials with immune therapeutics 2016 Menis J. + ANNALS OF TRANSLATIONAL MEDICINE - -
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061) 2016 Menis J. + EUROPEAN JOURNAL OF CANCER - -
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study 2016 Menis, Jessica + LUNG CANCER - -
Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064) 2015 Menis, Jessica + EUROPEAN JOURNAL OF CANCER - -
Methodology of clinical trials in lung cancer 2015 Menis J. + CHINESE CLINICAL ONCOLOGY - -
New clinical research strategies in thoracic oncology: Clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response 2014 Menis J. + EUROPEAN RESPIRATORY REVIEW - -
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation 2014 Menis, Jessica + EUROPEAN JOURNAL OF CANCER - -
MET inhibition in lung cancer 2013 Menis J. + TRANSLATIONAL LUNG CANCER RESEARCH - -
Brain metastases from gastrointestinal tumours: Tailoring the approach to maximize the outcome 2013 Menis, JessicaFONTANELLA, CATERINA + CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - -
HER-2 expression in brain metastases from colorectal cancer and corresponding primary tumors: A case cohort series 2013 Menis J. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
A computational index derived from whole-genome copy number analysis is a novel tool for prognosis in early stage lung squamous cell carcinoma 2012 Menis, Jessica + GENOMICS - -
Fulminating septic shock from Clostridium perfringens in an early breast cancer patient with severe myalgia after docetaxel treatment 2011 Menis, Jessica + CLINICS AND PRACTICE - -
Eribulin (Halaven): A new, effective treatment for women with heavily pretreated metastatic breast cancer 2011 Menis, J. + BREAST CANCER - -
Mostrati risultati da 21 a 40 di 42
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile